CytomX Therapeutics Financial Overview
CytomX Therapeutics's market cap is currently $743.82M. The company's EPS TTM is $-0.09; its P/E ratio is 10.50; CytomX Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
